Table 1.
Baseline demographic, clinical, and angiographical characteristics of the study populations
| Variables | Group 1 restenosis (−) | Group 2 restenosis (+) | P value |
|---|---|---|---|
| CAR | 1.01 (0.6‐1.38) | 3.8 (1.7‐4.9) | <0.001 |
| SS | 16.5 ± 4.4 | 16.8 ± 4.5 | 0.44 |
| Sex (Male %) | 85.8 | 81.4 | 0.187 |
| Age (y) | 53 ± 11.1 | 56 ± 12 | 0.036 |
| DM (%) | 30.4 | 27.3 | 0.43 |
| HT (%) | 33.6 | 41.9 | 0.05 |
| COPD (%) | 5.5 | 5.5 | 0.95 |
| Smoking (%) | 63.6 | 61.7 | 0.646 |
| Dyslipidemia (%) | 42.7 | 44.7 | 0.654 |
| Aspirin (%) | 1.2 | 4.3 | 0.003 |
| Killip class (%) | |||
| 1 | 87 | 85.5 | 0.67 |
| 2‐4 | 13 | 14.6 | |
| TIMI risk score | 1 (1‐3) | 2 (1‐4) | <0.001 |
| WBC (*103) | 12.1 ± 3.6 | 11.7 (9.6‐14) | 0.94 |
| Neutrophils (*103) | 8.6 (6.7‐11.5) | 8.8 (7‐11.2) | 0.85 |
| Lymphocytes (*103) | 1.7 (1.3‐2.46) | 1.8 (1.2‐2.4) | 0.87 |
| HGB (*103) | 13.9 ± 1.7 | 13.6 ± 1.7 | 0.028 |
| Platelets (*103) | 246 (210‐295) | 249 (217‐294) | 0.55 |
| Cr (mg/dL) | 0.9 ± 0.26 | 0.92 ± 0.32 | 0.77 |
| Glucose (mg/dL) | 125 (105‐185) | 133 (110‐171) | 0.143 |
| Uric acid (mg/dL) | 4.9 ± 0.2 | 5.1 ± 1.4 | 0.156 |
| Albumin (mg/dL) | 3.8 ± 0.49 | 3.7 ± 0.48 | 0.001 |
| CK (U/L) | 276 (146‐447) | 335 (170‐566) | 0.007 |
| CK‐MB (U/L) | 34 (23‐44) | 34 (23‐45) | 0.232 |
| Troponin T (ng/dL) | 1.5 (0.34‐3.7) | 2.2 (0.7‐4.6) | 0.021 |
| LDL (mg/dL) | 113 (87‐145) | 110 (87‐140) | 0.590 |
| Triglyceride (mg/dL) | 116 (79‐168) | 111 (81‐164) | 0.75 |
| CRP (mg/L) | 3.8 (2.5‐5.4) | 11 (6‐18) | <0.001 |
| EF (%) | 48 ± 7.2 | 46 ± 7.6 | 0.02 |
| IRA (%) | |||
| LMCA | 0.4 | 0.4 | 0.213 |
| LAD | 49.8 | 50.2 | |
| CX | 10.7 | 14.2 | |
| RCA | 38.7 | 34.4 | |
| Others | 0.4 | 0.8 | |
| Localization (%) | |||
| Proximal | 49.8 | 55.3 | 0.208 |
| Mid region | 45.3 | 41.1 | |
| Distal region | 4.3 | 3.6 | |
| Stent type (DES, (%) | 36 | 30 | 0.05 |
| No reflow (%) | 20.9 | 30 | 0.169 |
| MBG | 3 (2‐3) | 2 (1‐3) | 0.004 |
| CTFC | 20 (15‐25) | 22 (17‐27) | 0.01 |
CAR, CRP to albumin ratio; CK, creatine kinase; COPD, chronic obstructive pulmonary disease; Cr, creatine; CRP, C‐reactive protein; CTFC, corrected TIMI frame count; EF, ejection fraction; HGB, hemoglobulin; HT, hypertension; IRA, infarct‐related artery; LDL, low‐density lipoprotein; MBG, myocardial blush grade; MD, diabetes mellitus; SS, syntax score; WBC, white blood count.
Bold values indicates statistical significant values.